Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS

BACKGROUND: Whether airspace biomarkers add value to plasma biomarkers in studying acute respiratory distress syndrome (ARDS) is not well understood. Mesenchymal stromal cells (MSCs) are an investigational therapy for ARDS, and airspace biomarkers may provide mechanistic evidence for MSCs’ impact in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wick, Katherine D., Leligdowicz, Aleksandra, Zhuo, Hanjing, Ware, Lorraine B., Matthay, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262503/
https://www.ncbi.nlm.nih.gov/pubmed/33974564
http://dx.doi.org/10.1172/jci.insight.148983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262503/
https://www.ncbi.nlm.nih.gov/pubmed/33974564
http://dx.doi.org/10.1172/jci.insight.148983

Ejemplares similares